SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > US OTC > Cannabis > OWC Pharmaceutical Research Corp. (OWCP)

I believe that the issue is toxicity of

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
onco Member Profile
Member Level 
Followed By 45
Posts 4,338
Boards Moderated 0
Alias Born 04/08/06
160x600 placeholder
Annual Statement of Changes in Beneficial Ownership (5) "Edgar (US Regulatory)" - 6/22/2017 1:44:13 PM
Annual Statement of Changes in Beneficial Ownership (5) "Edgar (US Regulatory)" - 6/22/2017 1:30:15 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 6/21/2017 4:38:40 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 6/21/2017 4:16:13 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/15/2017 6:04:02 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/8/2017 6:04:20 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/30/2017 4:25:07 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/18/2017 11:35:53 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 5/15/2017 12:05:03 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 5/5/2017 4:59:52 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/3/2017 6:06:16 AM
Stocks with Key Influences on the Horizon and New Coverage in the Mobile Tech Space "InvestorsHub NewsWire" - 4/20/2017 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/19/2017 3:00:46 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 4/17/2017 5:15:25 PM
Grey Cloak Tech, Inc. (OTC Pink: GRCK), Acquires $6.4mm ShareRails, Inc. – $1.7 million in Sales, 300% Growth "InvestorsHub NewsWire" - 4/12/2017 8:49:04 AM
Grey Cloak Tech, Inc. (OTC Pink: GRCK), Acquires $6.4mm ShareRails, Inc. – $1.7 million in Sales, 300% Growth "InvestorsHub NewsWire" - 4/12/2017 8:47:59 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/4/2017 4:19:40 PM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 3/31/2017 11:20:52 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/20/2017 4:32:58 PM
Unique Cannabis-Pharma Companies Trailblazing the Medical Cannabis Industry "NetworkNewsWire" - 3/16/2017 9:30:00 AM
Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth "NetworkNewsWire" - 3/15/2017 9:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/24/2017 4:03:55 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/7/2017 6:06:08 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/2/2017 9:15:23 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/26/2017 5:15:05 PM
onco Member Level  Monday, 03/20/17 09:13:26 PM
Re: kbaz post# 73500
Post # of 98434 
I believe that the issue is toxicity of the treatments the side effects of the treatments appear to be minimal and extremely priced lower than the the other choices IMO

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist